Search

Adam Cantor brings more than 25 years of legal experience to his new role as a partner in Saul Ewing’s Employee Benefits and Executive Compensation Practice, including advising clients on a wide array of executive and equity compensation, deferred compensation, and employee benefits matters. He also...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...